Refractive Results: Safety and Efficacy of Secondary Piggyback Sensar™ AR40 Intraocular Lens Implantation to Correct Pseudophakic Refractive Error

Abstract EN

In this study we evaluate the visual outcomes, safety, efficacy, and stability of implanting of second sulcus intraocular lens (IOL) to correct unsatisfied ametropic patients after phacoemulsification.

Methods.

Retrospective study of 15 eyes (15 patients) underwent secondary intraocular lens implanted into the ciliary sulcus.

The IOL used was a Sensar IOL three-piece foldable hydrophobic acrylic IOL.

The first IOL in all patients was acrylic intrabagal IOL implanted in uncomplicated phacoemulsification surgery.

Results.

Fifteen eyes (15 patients) were involved in this study.

Preoperatively, mean logMAR UDVA and CDVA were 0.88 ± 0.22 and 0.19 ± 0.13, respectively, with a mean follow-up of 28 months (range: 24 to 36 months).

At the end of the follow-up, all eyes achieved logMAR UDVA of 0.20 ± 0.12 with postoperative refraction ranging from 0.00 to −0.50 D of attempted emmetropia.

Conclusions.

Implantation of the second sulcus SensarAR40 IOL was found to be safe, easy, and simple technique for management of ametropia following uncomplicated phacoemulsification.